L. reuteri ATCC PTA 6475.

Galactooligosaccharides pass undigested to the colon, where lactobacilli ferment them to lactate and short-chain fatty acids. A young child formula pairing Limosilactobacillus reuteri with GOS was studied for gut microbiome composition and growth measures, so the two have been given together rather than only inferred. The microbiome readouts are compositional markers, not clinical outcomes.

Inulin is a fructan that human enzymes cannot hydrolyse, so it reaches the colon intact and is fermented by resident lactic acid bacteria. Supplying fermentable substrate alongside a live strain gives that strain something to grow on. This is substrate provision, not a demonstrated clinical additive effect.

Short-chain fructooligosaccharides are fermented preferentially by lactobacilli and bifidobacteria in the proximal colon. Formulators pair them with lactic acid bacteria for that reason. The pairing is formulation convention supported by fermentation biochemistry rather than by a trial of this specific strain.

Vitamin D governs intestinal calcium absorption, which sets how much mineral is available for normal bone turnover. L. reuteri ATCC PTA 6475 has been studied for its effect on bone mineral density in early postmenopausal women, a marker of skeletal mineral handling. Any bone-related contribution of the strain still depends on adequate calcium and vitamin D status.

Calcium is the substrate for hydroxyapatite and no microbial signal can compensate for an inadequate intake. Colonic fermentation lowers luminal pH, which keeps calcium in a soluble ionised state available for passive absorption. That mechanism is established for fermentative organisms generally.

Menaquinone-7 is the cofactor for gamma-glutamyl carboxylase, the enzyme that carboxylates osteocalcin so it can bind calcium into bone matrix. It sits downstream of mineral supply rather than competing with it. Pairing addresses a different step in normal bone mineral handling than a live strain does.

Limosilactobacillus reuteri is one of the few lactobacilli carrying the cobalamin biosynthesis operon, and it uses a B12-dependent diol dehydratase to convert glycerol to reuterin. Colonic synthesis sits distal to the ileal absorption site, so microbial production is not a reliable dietary source. Regard the relationship as biochemical rather than as a way to raise B12 status.

Several lactobacilli synthesise folate in the colon and a systematic review has mapped the two-way relationship between dietary folate and enteric microbial populations. Colonic folate is absorbed by a proton-coupled transporter, so it is not simply discarded. The strain-specific yield varies widely and is not established for this strain.

An oral rehydration solution enriched with both L. reuteri DSM 17938 and zinc has been studied in children for gastrointestinal recovery measures. That trial used a different strain from ATCC PTA 6475, so it supports the pairing concept rather than this strain. Zinc contributes independently to normal intestinal barrier function.

Saccharomyces boulardii is a yeast, so it occupies a different niche from a lactic acid bacterium and is unaffected by most antibacterial pressures. Multi-organism blends are built on that non-overlap. The combination has not been characterised for this specific strain pairing.

Multi-strain blends combine species with different fermentation profiles and adhesion patterns to widen colonic coverage. L. plantarum is obligately heterofermentative in part and tolerates a broad pH range. Strains within a blend can also compete for the same substrate, so more strains is not automatically more effect.

Bifidobacteria ferment oligosaccharides to acetate and lactate, which lactobacilli and butyrate producers use in cross-feeding chains. That metabolic hand-off is well described in colonic ecology. Whether it changes any measured outcome when the two are taken together has not been established for this strain.

Resistant starch escapes small-intestinal amylase and is fermented in the distal colon, further along than inulin or FOS reach. Pairing a live strain with a slowly fermented substrate extends fermentation deeper into the bowel. The effect is on substrate availability, not on strain survival through the stomach.

Lactoferrin binds free iron tightly, which restricts iron available to iron-requiring enteric organisms. Lactobacilli are unusual in having little or no iron requirement, so they are comparatively unaffected by that sequestration. The selective pressure is a plausible mechanism rather than a measured combination effect.

Bovine colostrum supplies secretory immunoglobulins and oligosaccharides that reach the colon largely intact. The oligosaccharide fraction is fermentable by lactobacilli. This is substrate and barrier support alongside a live organism, not a tested pairing for this strain.